1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legal

Tom’s ‘Naturally Dry’ Claims Survived Class Action, Only To Perish At NAD

 
• By Ryan Nelson

Companies that have settled lawsuits regarding the truthfulness of “natural” or other claims should take note of the National Advertising Review Board’s decision on jurisdictional issues raised last year by Colgate. The firm argued unsuccessfully that the National Advertising Division should not have reviewed Tom’s of Maine Naturally Dry antiperspirant claims because they were the subject of a court-approved class settlement.

grief on cemetery / withered yellow rose on gravestone / sorrow about loss

The Colgate-Palmolive Company settled a false-advertising class action last year without having to scrub its Tom’s of Maine products of “natural” labeling, but its run with Naturally Dry antiperspirants has come to an end following a contentious advertising self-regulatory ordeal.

The firm will be renaming its Naturally Dry products, as recommended by the National Advertising Division in September 2016, despite disagreeing with the Council of Better

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.

Cosmetics Consortium Shares Studies With FDA To Build Confidence In Animal Testing Alternatives

 
• By Lauren Nardella

By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By Eileen Francis and Lauren Nardella

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.